Douglas M. Hunt

CIK: 0001727172

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PBYI

PUMA BIOTECHNOLOGY, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

PBYI
PUMA BIOTECHNOLOGY, INC.
Jul 6, 2026
Sale(S)
Direct
8.5K shares at avg. $8.26$70K
PBYI
PUMA BIOTECHNOLOGY, INC.
Feb 18, 2026
Award(A)
Direct
49.4K shares-
PBYI
PUMA BIOTECHNOLOGY, INC.
Jan 7, 2026
Sale(S)
Direct
5K shares at avg. $5.88$29K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jan 6, 2026
Sale(S)
Direct
4K shares at avg. $5.84$23K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jul 9, 2025
Sale(S)
Direct
3.4K shares at avg. $3.54$12K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jul 8, 2025
Sale(S)
Direct
4.4K shares at avg. $3.53$15K
PBYI
PUMA BIOTECHNOLOGY, INC.
Feb 7, 2025
Award(A)
Direct
48.1K shares-
PBYI
PUMA BIOTECHNOLOGY, INC.
Jan 2, 2025
Sale(S)
Direct
8.6K shares at avg. $3.15$27K

		Type	Shares	Price		Ownership
Jul 6, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	8,460	$8.26	$69,905	Direct
Feb 18, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Award(A)	49,394	-	$0	Direct
Jan 7, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	5,014	$5.88	$29,477	Direct
Jan 6, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	3,973	$5.84	$23,218	Direct
Jul 9, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	3,443	$3.54	$12,171	Direct
Jul 8, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	4,374	$3.53	$15,453	Direct
Feb 7, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Award(A)	48,117	-	-	Direct
Jan 2, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	8,633	$3.15	$27,209	Direct

1-8 of 8 transactions

About HUNT DOUGLAS M

HUNT DOUGLAS M (SEC CIK 0001727172) files insider reports with the SEC as Officer of PUMA BIOTECHNOLOGY, INC. (PBYI).

Signal8 holds 6 ownership filings by HUNT DOUGLAS M, all Form 4s, filed between Jan 3, 2025 and Jul 8, 2026. Those filings report 8 transactions, from Jan 2, 2025 to Jul 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on HUNT DOUGLAS M's filings is in LOS ANGELES, CA.

Recent filings by HUNT DOUGLAS M

Jul 6, 2026: Open-market sale of PBYI shares (Form 4, code S).
Feb 18, 2026: Grant or award of PBYI shares (Form 4, code A).
Jan 7, 2026: Open-market sale of PBYI shares (Form 4, code S).
Jan 6, 2026: Open-market sale of PBYI shares (Form 4, code S).
Jul 9, 2025: Open-market sale of PBYI shares (Form 4, code S).

Other insiders filing for PUMA BIOTECHNOLOGY, INC. (PBYI)

WILSON TROY EDWARD, Director
Cesano Alessandra, Director
AUERBACH ALAN H, President and CEO
NOUGUES MAXIMO F, Chief Financial Officer
Stuglik Brian M, Director
Senderowicz Adrian, Director

How to read Form 4 transaction codes